Safety of Tralokinumab for the Treatment of Atopic Dermatitis in Patients with Up to 4.5 Years of Treatment: An Updated Integrated Analysis of Eight Clinical Trials . J of Skin. 2024;8(2):s375. doi:10.25251/skin.8.supp.375